Diego silva

Company: Vaxine

Job title: Managing Director

Seminars:

Engineering Anti-Tumor Immunity: Strategic Design of Vaccine Constructs to Activate Durable & Potent Immune Responses 5:00 pm

• Leveraging clinical insights from an ongoing Phase I trial to guide the design of personalized vaccine constructs • Selecting optimal vectors, adjuvants, and delivery mechanisms to stimulate strong CD8+ T cell and memory responses • Translating immunogenicity data into design refinements to overcome tumor immune evasionRead more

day: Conference Day One